Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Pneumococcal Infection: early-phase trial registry

1 of 2 indexed Pneumococcal Infection trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Pneumococcal Infection: 2 US clinical trials tracked, 1 recruiting.

Pneumococcal Infection is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Emory University, running 1 of these trials.

Enrollment posture brief

Registry condition pneumococcal-infection

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Pneumococcal Infection (this)50%
Open-enrollment share among volume-matched conditions near Pneumococcal Infection

Pneumococcal Infection lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pneumococcal Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pneumococcal Infection is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Pneumococcal Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Prevnar Biological
1 trials
PNEUMOVAX Biological
1 trials
PCV20 (Stage 2) Biological
1 trials
PCV20 (Stage 1) Biological
1 trials
V118C (Stage 2) Biological
1 trials
V118C (Stage 1) Biological
1 trials

US sites by state

Facility locations filed on Pneumococcal Infection trials. A trial with sites in several states counts in each.

Virginia 1 trials
Texas 1 trials
South Carolina 1 trials
New York 1 trials
Missouri 1 trials
Kentucky 1 trials
Kansas 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pneumococcal Infection page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Pneumococcal Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Emory University sponsors the most Pneumococcal Infection trials on record, review their full trial history before evaluating a specific study. See Emory University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pneumococcal Infection condition card totals 2 registered trials; most-linked intervention Prevnar; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.